1. Parkin DM, Pisani P, Ferlay J. Estimates of the worldwide incidence frequency of eighteen major cancers in 1985. Int J Cancer. 1993; 54:594–606.
2. Lee YC. Gastric adenoma: follow up? Spring conference of Korean Gastroenterol. 2005. 101–108.
3. Lee DS, Kang SB, Baek JT, et al. Immunohistochemical expression of Bcl-2, Bcl-xL, Bax, p53 proteins in gastric adenoma and adenocarcinoma. Korean J Gastroenterol. 2005; 45:394–400.
Article
4. Gorgoulis VG, Vassiliou LV, Karakaidos P, et al. Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions. Nature. 2005; 434:907–913.
Article
5. Halazonetis TD, Gorgoulis VG, Bartek J. An oncogene-induced DNA damage model for cancer development. Science. 2008; 319:1352–1355.
Article
6. Bal N, Yildirim S, Nursal TZ, Bolat F, Kayaselcuk F. Association of ezrin expression in intestinal and diffuse gastric carcinoma with clinicopathological parameters and tumor type. World J Gastroenterol. 2007; 13:3726–3729.
Article
7. Kobayashi J, Iwabuchi K, Miyagawa K, et al. Current topics in DNA double-strand break repair. J Radiat Res. 2008; 49:93–103.
Article
8. Bonner WM, Redon CE, Dickey JS, et al. GammaH2AX and cancer. Nat Rev Cancer. 2008; 8:957–967.
9. Ismail IH, Hendzel MJ. The gamma-H2AX: is it just a surrogate marker of double-strand breaks or much more? Environ Mol Mutagen. 2008; 49:73–82.
10. Kinner A, Wu W, Staudt C, Iliakis G. Gamma-H2AX in recognition and signaling of DNA double-strand breaks in the context of chromatin. Nucleic Acids Res. 2008; 36:5678–5694.
11. Roos WP, Kaina B. DNA damage-induced cell death by apoptosis. Trends Mol Med. 2006; 12:440–450.
Article
12. Bartkova J, Horejsí Z, Koed K, et al. DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis. Nature. 2005; 434:864–870.
Article
13. Fauci AS, Braunwald E, Kasper DL, et al. Harrison's principles of internal medicine. 17th ed.New York: The McGraw-Hill Companies;2008. 573-574.
14. Halazonetis TD, Gorgoulis VG, Bartek J. An oncogene-induced DNA damage model for cancer development. Science. 2008; 319:1352–1355.
Article